KNR Constructions gives trendline breakout
KNR Constructions gives trendline breakout

KNR Constructions gives trendline breakout

Vinayak Gangule Article rating: 5.0

The stock of KNR Constructions Limited has given a downward sloping trendline breakout on the weekly timeframe, formed by connecting swing highs from December 2017. Further, the breakout is supported by a robust volume of more than double of the 50-week average volume, indicating a strong buying interest by the market participants.

Sensex jumps more than 400 points; IRCTC surges 14 per cent, Laurus Labs gains 4 per cent, SpiceJet zooms 10 per cent
Sensex jumps more than 400 points; IRCTC surges 14 per cent, Laurus Labs gains 4 per cent, SpiceJet zooms 10 per cent

Sensex jumps more than 400 points; IRCTC surges 14 per cent, Laurus Labs gains 4 per cent, SpiceJet zooms 10 per cent

DSIJ Intelligence Article rating: 4.9

On Friday, the domestic benchmark indices touched record highs as Sensex closed at 45,079.55 levels, up by 446.90 points or 1 per cent while Nifty gained by 124.65 points or 0.95 per cent to settle at 13,258.55 levels.

Airtel jumps almost 3 per cent after TRAI reports of adding more subscribers than Jio in September
Airtel jumps almost 3 per cent after TRAI reports of adding more subscribers than Jio in September

Airtel jumps almost 3 per cent after TRAI reports of adding more subscribers than Jio in September

DSIJ Intelligence Article rating: 5.0

The shares of Bharti Airtel were trading in the green on Friday after Telecom Regulatory Authority of India (TRAI) in its subscription data report revealed that for the month of September 2020, Airtel reigned supreme with more than 3.77 million subscriber addition, followed by Reliance Jio, which managed to add 1.46 million new subscribers in comparison.

Zydus gets nod for conducting phase III clinical trials of its much-awaited COVID vaccine
Zydus gets nod for conducting phase III clinical trials of its much-awaited COVID vaccine

Zydus gets nod for conducting phase III clinical trials of its much-awaited COVID vaccine

Abhinav Lahoti Article rating: 5.0

Zydus Cadila today announced that it has received permission to start the phase III clinical trials in the COVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, ‘PegiHepTM’ from Drugs Controller General of India (DCGI).  The trials will be conducted on 250 patients across 20-25 centres in India, starting in December.

IRCTC surges over 12 per cent; gives trendline breakout
IRCTC surges over 12 per cent; gives trendline breakout

IRCTC surges over 12 per cent; gives trendline breakout

Vinayak Gangule Article rating: 3.9

On Friday, the stock Indian Railway Catering & Tourism Corporation Limited has surged over 12 per cent and marked an intraday high of Rs 1,597. Technically, the stock has given a downward sloping trendline breakout on the daily timeframe formed by connecting swing highs since June 2020.

RSS
First26462647264826492651265326542655Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR